Although it was first described in classical Hodgkin’s lymphoma (cHL) and ALCL, CD30 expression is confined to medium/large active B and/or T-lymphocytes in normal or inflamed tissues [120,121]. This evidence concerns the gene TNFRSF8 and anaplastic large cell lymphoma.